Dtb Podcast

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Mixtard 30 - going, going, gone? Ulipristal – a new emergency contraceptive pill Management of fibromyalgia Agomelatine for major depressive episodes

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Money, money, money Preventing exacerbations in COPD Febuxostat for gout How medical devices are regulated in the UK

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Why pregabalin? DTB 2010; 48: 61 Acupuncture for tension-type headaches and migraine DTB 2010; 48: 62 - 5 Misoprostol for postpartum haemorrhage DTB 2010; 48: 66 - 9 Testosterone for ‘late-onset hypogonadism’ in men? DTB 2010; 48: 69 - 72

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Alcoholic neglect DTB 2010; 48: 49 Liraglutide for type 2 diabetes? DTB 2010; 48: 50 - 3 Grazax for hay fever – what’s new? DTB 2010; 48: 54 - 6 I.V. immunoglobulin therapy for infectious diseases DTB 2010; 48: 57 - 60

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: The computer says “no”? DTB 2010; 48: 37 Silver dressings – do they work? DTB 2010; 48: 38 - 42 Vagus nerve stimulation for epilepsy DTB 2010; 48: 42 - 45 Herbal medicines – what do clinicians know? DTB 2010; 48: 46 - 47

This month, we publish the results of a Drug and Therapeutics Bulletin Survey on Herbal Medicines, an online research designed to explore healthcare professionals’ knowledge of and attitudes towards herbal medicines. In this podcast, Dr Ike Iheanacho, DTB Editor, and David Phizackerley, DTB Deputy Editor, discuss the results of the survey, and issues related to the use and regulation herbal medicines, with Dr Linda Anderson, Principal Pharmaceutical Assessor at the MHRA and Mr Michael McIntyre, Chairman of the European Herbal and Traditional Medicine Practitioners Association. The results of DTB Survey on Herbal Medicines are available on our website, dtb.bmj.com.

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: A risky business? DTB 2010; 48: 25 Using NSAIDs in cardiovascular disease DTB 2010; 48: 26 - 29 Managing primary hyperparathyroidism in primary care DTB 2010; 48: 30 - 33 Body surface area for adjustment of drug dose DTB 2010; 48: 33 - 36

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Patient safety first? DTB 2010; 48: 13 Management of community-associated MRSA DTB 2010; 48: 14 - 19 ▼Pregabalin for generalised anxiety disorder DTB 2010; 48: 19 - 22 A change of units for HbA1c DTB 2010; 48: 23 - 24 Conversion chart for HbA1c values

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: More on high street mole checks DTB 2010; 48: 1 Management of medication overuse headache DTB 2010; 48: 2 - 6 Cognitive behavioural therapy for schizophrenia DTB 2010; 48: 6 - 9 Tocilizumab for rheumatoid arthritis DTB 2010; 48: 9 - 12

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: C. difficile outside hospital DTB 2009; 47: 133 Managing gastro-oesophageal reflux in infants DTB 2009; 47: 134 - 137 Strong opioids for osteoarthritis in primary care? DTB 2009; 47: 138 - 141 Generic prescribing in epilepsy DTB 2009; 47: 141 - 144

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Uncommon knowledge DTB 2009; 47: 121 Aspirin for primary prevention of cardiovascular disease? DTB 2009; 47: 122 - 125 Over-the-counter weight loss with orlistat? DTB 2009; 47: 125 - 127 Management of seasonal affective disorder DTB 2009; 47: 128 - 132

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Generically speaking DTB 2009; 47: 109 Does BNP testing aid diagnosis of heart failure? DTB 2009; 47: 110 - 113 Imiquimod for superficial and in situ skin malignancy DTB 2009; 47: 113 - 116 Anticoagulation with dabigatran or rivaroxaban DTB 2009; 47: 116 - 120

The widespread use of oseltamivir (Tamiflu) has been a key strategy in tackling the H1N1 ‘swine flu’ pandemic in the UK. However, there have been growing concerns about the communication of this approach and rationale behind the policy itself. In this podcast Dr Ike Iheanacho, DTB editor, discusses the policy with two members of the DTB editorial board, Dr Paul Caldwell, a general practitioner and Dr Mahdad Noursadeghi, an infectious diseases consultant. This is an extension of our September 2009 Editorial, Tamiflu − the wrong message? DTB 2009; 47: 97.

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Tamiflu − the wrong message? DTB 2009; 47: 97 Self-monitoring for patients on warfarin? DTB 2009; 47: 98 - 101 Non-drug management of chronic low back pain DTB 2009; 47: 102 - 108 Correction: How to misinform patients DTB 2009; 47: 108

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: How to misinform patients DTB 2009; 47: 85 Management of carpal tunnel syndrome DTB 2009; 47: 86 - 89 So, what exactly is a cytokine? DTB 2009; 47: 89 - 91 Ezetimibe – an update DTB 2009; 47: 91 - 95 Understanding statistical terms: 5 – systematic reviews and meta-analyses DTB 2009; 47: 95 - 96

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Only in England DTB 2009; 47: 73 Melatonin for primary insomnia? DTB 2009; 47: 74 - 77 Which approach for first trimester miscarriage? DTB 2009; 47: 77 - 80 What are excipients doing in medicinal products? DTB 2009; 47: 81 - 84

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: Real costs of end-of-life drugs DTB 2009; 47: 61 Management of benign paroxysmal positional vertigo DTB 2009; 47: 62 - 66 Interferon-gamma release assays and TB diagnosis DTB 2009; 47: 67 - 70 Understanding statistical terms: 4 – Diagnostic tests DTB 2009; 47: 71 - 72

In January 2009, NICE began a policy for valuing the use of drugs for extending life in people with a short life-expectancy. This development arose from concerns that NICE had been denying patients life-extending treatments because they were too expensive. However, the new policy also raises important ethical and moral dilemmas. In this podcast Dr Martin Duerden, General Practitioner and member of the DTB editorial board, and Dr Ike Iheanacho, DTB Editor, discuss this policy and the issues it raises. This is an extension of our June 2009 Editorial, Real costs of end-of-life drugs DTB 2009; 47: 61.

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: The mad world of epilepsy drugs DTB 2009; 47: 49 Update on treatments for head lice DTB 2009; 47: 50 - 52 What role for colesevelam in cardiovascular prevention? DTB 2009; 47: 53 - 5 Why look at an SPC? DTB 2009; 47: 56 - 58 Understanding statistical terms: 3 DTB 2009; 47: 59 - 60

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: What are you on? DTB 2009; 47: 37 Preventing recurrent venous thromboembolism. DTB 2009; 47: 38 - 41 Drospirenone in HRT? DTB 2009; 47: 41 - 4 The licensing of medicines in the UK. DTB 2009; 47: 45 – 48